Thanks for the notes as I missed the presentation. In regards to item 2) -
I'm a bit confused on your last sentence... Is that something lost in translation or something Daniel really said/meant? If this trial doesn't impact the long term value of the company why would we be running it, and at considerable expense to the company given the cost of the drugs?
Thanks for any clarity you can add.
RAC media coverage, page-854
-
- There are more pages in this discussion • 1,435 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.60 |
Change
0.040(2.56%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.61 | $1.57 | $49.84K | 31.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5361 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 200 | 1 |
View Market Depth
| Last trade - 10.25am 26/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |